American Heart Journal
Volume 144, Issue 6 , Pages 957-980 , December 2002

Changing the diagnosis of acute myocardial infarction: Implications for practice and clinical investigations

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by unrestricted educational grants from: Aventis Pharmaceuticals, Abbott Diagnostic, COR Therapeutics, Inc., First Medical, The Medicines Company, Merck & Co., Pfizer Inc., Proctor & Gamble Pharmaceuticals, Roche Diagnostics Corporation, Schering-Plough Research Institute, Wyeth-Ayerst Research

☆☆ Reprint requests: L. Kristin Newby, MD, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715-7969.

★ E-mail: newby001@mc.duke.edu

★★ *A complete list of participants is listed in the Appendix.

PII: S0002-8703(02)00220-X

doi: 10.1067/mhj.2002.129778

American Heart Journal
Volume 144, Issue 6 , Pages 957-980 , December 2002

Article Tools

* Image Usage & Resolution